Chairman & CEO. “Faisal has a proven track record in integrating cutting-edge science with practical, evidence-base PHILADELPHIA, October 24, 2024--New data for AREXVY, GSK’s RSV vaccine ...

IPOBIOVERSYS SUCCESSFULLY COMPLETES ITS IPO AT CHF 36 PER SHARE AND STARTS TRADING ON THE SIX SWISS EXCHANGE TOMORROW, FEBRUARY 07, 2025 06.02.2025 / 07:00 CET/CEST__________THIS IS A RESTRICTED ...

Look deep into nature and then you will understand everything better.” The quote from Albert Einstein is generally deployed to highlight the intuitive interconnectedness of the natural world; but it ...

Ouro Medicines’ name is short for ouroboros, an ancient symbol of a snake eating itself for eternal recycling, rebirth and renewal. A San Francisco startup, founded by Big Pharma player GSK plc ...

Monograph Capital participated in the round and also founded the company in partnership with GSK, according to a Jan ... so that they’re replaced by new, healthy cells is a common goal of ...

The question of the rights and wrongs of playing cricket against the Afghanistan men’s team is never far from the surface.

Dynavax should take a leaf from its vaccine maker peer, Novavax, and work to monetize its CpG1018 adjuvant. Learn more about ...

Vaxxas, a clinical-stage biotechnology company, today announced the appointments of three globally respected vaccine experts as advisors to its product development and strategy team as the company ...

Estun , established in 1993, is a leading player in China's robotics market. The company produces a wide range of industrial ...

On a per-share basis, the Jersey City, New Jersey-based company said it had ... payment under its exclusive license agreement with GSK for ibrexafungerp. The milestone payment is triggered by ...